The University of Minnesota said Wednesday that its researchers have successfully repaired damaged skin tissue using stem cells gleaned from bone marrow.
In a study published Thursday in the New England Journal of Medicine, researchers from the school’s Stem Cell Institute said the therapy can help patients who suffer from recessive dystrophic epidermolysis bullosa (RDEB), a painful genetic skin disorder that causes skin to blister and scrape off with the slightest friction or trauma.
Even more importantly, the study shows these stem cells can form something other than bone marrow. Unlike embryonic stem cells, which can develop into any tissue, doctors have used bone marrow stem cells only to repair bone marrow.
Behavioral Health, Interoperability and eConsent: Meeting the Demands of CMS Final Rule Compliance
In a webinar on April 16 at 1pm ET, Aneesh Chopra will moderate a discussion with executives from DocuSign, Velatura, and behavioral health providers on eConsent, health information exchange and compliance with the CMS Final Rule on interoperability.
“Whether stem cells from marrow could repair tissues other than itself has been quite controversial,” Dr. John Wagner, director of pediatric blood and marrow transplantation, and clinical director of the Stem Cell Institute, said in a statement. “But in 2007, we found a rare subpopulation of marrow stem cells that could repair the skin in laboratory models. This astounding finding compelled us to test these stem cells in humans. This has never been done before.”
Researchers say that the stem cells can bond to the skin and upper gastrointestinal tract, and boost levels of collagen 7, a protein that instructs layers of skin to stick together and to the body. Patients suffering from RDEB lack collagen 7.
The scientists, however, caution that the treatment is risky and two patients in the study have died from complications related to the therapy.
Nevertheless, the study augments the school’s already impressive work in regenerative medicine.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Last month, researchers at the Masonic Cancer Center and medical school said they grew breathing lungs from a rat in laboratory. In 2008, Doris Taylor drew international attention for successfully growing — and keeping alive — a beating rat’s heart in a jar. Taylor’s work has fueled hopes that scientists can one day grow replacement organs for patients who would typically wait for transplants. The university this year spun off Miromatrix Inc., a startup meant to commercialize Taylor’s work.
